Previous 10 | Next 10 |
home / stock / mrvl / mrvl articles
Broadcom Inc (NASDAQ:AVGO) announced it anticipates $10 billion in AI-related chip revenue this year but saw its stock drop after its yearly f...
Broadcom Inc (NASDAQ:AVGO) announced it anticipates $10 billion in AI-related chip revenue this year but saw its stock drop after its yearly f...
U.S. stock futures were mixed this morning, with the Dow futures falling by around 30 points on Friday. Shares of AerSale Corporation (NASDAQ: AS...
Marvell Technology Inc (NASDAQ:MRVL) reported fourth-quarter financial results Thursday after the close. Here’s a look at the key m...
March kicked off on a high note on Wall Street Friday, with both the S&P 500 and Nasdaq 100 indices soaring to unprecedented heights, fueled by...
Marvell Tech (NASDAQ:MRVL) has outperformed the market over the past 10 years by 5.55% on an annualized basis producing an average annual return of...
Nvidia Corp’s (NASDAQ:NVDA) strategic expansion into custom AI chip design presents a formidable challenge to Broadcom Inc (NASDAQ:AVGO)...
Nvidia Corp (NASDAQ:NVDA) stock is trading higher Friday amid reports of the leading chip designer branching out to establish a new division d...
Marvell Tech (NASDAQ:MRVL) has outperformed the market over the past 5 years by 17.72% on an annualized basis producing an average annual return of...
News, Short Squeeze, Breakout and More Instantly...
Marvell Technology Inc. Company Name:
MRVL Stock Symbol:
NASDAQ Market:
Marvell Technology Inc. Website:
Calgary, Alberta--(Newsfile Corp. - July 19, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the " Company " or " Marvel "), is pleased to report that, further to its press releases of May 16, 2024 and June 21, 2024, it has ...
2024-07-15 18:00:00 ET Broadcom (NASDAQ: AVGO) and Marvell Technology (NASDAQ: MRVL) usually don't attract as much attention as higher-growth chipmakers like Nvidia (NASDAQ: NVDA) . But like Nvidia, both diversified chip specialists are benefiting from the rapid ...
Calgary, Alberta--(Newsfile Corp. - July 9, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to highlight the recently published paper "Neuronal A2A receptor exacerbate...